NCT06715423View on ClinicalTrials.gov

High Flow Nasal Oxygen Therapy an Implementation Study in Pediatric Wards

Not yet recruitingOBSERVATIONAL
Enrollment

960

Participants

Timeline

Start Date

January 31, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Moderate Respiratory DistressSevere Respiratory Distress
Trial Locations (1)

Unknown

Herat regional Hospital, Herat

Sponsors

Lead Sponsor

Epicentre
All Listed Sponsors
collaborator

MOH Afghanistan

UNKNOWN

collaborator

MOH Bangladesh

UNKNOWN

collaborator

MOH Sierra Leone

UNKNOWN

collaborator

MOH Yemen

UNKNOWN

collaborator

MSF Médecins Sans Frontières Belgium

UNKNOWN

collaborator

MSF Médecins Sans Frontières France

UNKNOWN

collaborator

Fisher and Paykel Healthcare

INDUSTRY

lead

Epicentre

OTHER

NCT06715423 - High Flow Nasal Oxygen Therapy an Implementation Study in Pediatric Wards | Biotech Hunter | Biotech Hunter